Specialized FSHD genetics can be a major diagnostic cost component
FSHD molecular diagnosis is not the same as a routine sequencing panel. FSHD1 assessment can involve D4Z4 repeat analysis and a permissive 4qA haplotype, while FSHD2 work-up can involve methylation and SMCHD1-related testing. If a complete report already exists, send it before travel so the center can decide whether anything needs repeating.
A clinical second opinion may not require a full repeat work-up
Patients with a confirmed diagnosis may mainly need a neuromuscular examination, progression review and functional planning. CK, EMG or muscle imaging are additional tests only when they answer a specific diagnostic or management question.
Rehabilitation and orthotics are recurring rather than one-time costs
Physiotherapy, occupational therapy, customized exercise, foot-drop orthoses, orthopedic footwear and mobility devices are often the main practical interventions. International patients should distinguish a German specialist assessment from the long-term therapy that may be more economical to continue locally.
Scapular surgery requires a separate neuro-orthopedic episode
Only a minority of FSHD patients are candidates for scapular fixation. Evaluation can involve shoulder-girdle examination, functional testing, imaging, anesthetic review and discussion of postoperative rehabilitation. Surgical costs should therefore be quoted only after candidacy is established.
Respiratory and sleep testing is phenotype-directed
Pulmonary-function testing, sleep-apnea screening or polysomnography may be added in severe or early-onset disease or when symptoms suggest nocturnal hypoventilation. Non-invasive ventilation setup, when needed, creates separate equipment and follow-up costs.
Hearing, ophthalmology and swallowing reviews are not universal packages
These assessments are most relevant when symptoms or early-onset/severe phenotype raise concern. A targeted approach avoids paying for tests that are unlikely to change management in a typical stable adult case.
Clinical-trial inquiries should remain separate from standard-care quotes
FSHD research includes experimental pharmacological and RNA-based approaches, but there is no approved disease-modifying drug. Trial eligibility, sponsor coverage and required research visits vary by protocol and should not be marketed as a paid treatment package.
Send records before requesting a German estimate
The center can define the scope more accurately when it sees the molecular diagnosis and current functional priorities.
- Complete FSHD genetic/molecular report
- Neuromuscular specialist reports
- Current functional limitations, work and mobility goals
- Physiotherapy and orthotic records
- Respiratory/sleep testing if previously performed
- Hearing, eye or swallowing reports when relevant
- Pain/fatigue treatment history
- Exact request: diagnostic confirmation, rehabilitation review, orthotics, scapular surgery opinion or clinical-trial inquiry
Official sources
Last source-reviewed 2026-09-01. Cost procedures and published service fees can change, so confirm current terms directly with the provider before transferring money or booking travel.